MW-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMW-001
Drug Alias NameRNX-005MWL-001MW-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Arachidonate 5-lipoxygenase
Therapy Area/IndicationsPsoriasisEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedwell Capital
China Registration ClassN/A

Develop Information

Active CompaniesMedwell Capital
Inactive CompaniesN/A
Active IndicationsPsoriasisEczemaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A